Harmony Biosciences Holdings, Inc. (HRMY)

NASDAQ

$38.85

$+0.10

(+0.25%)

Pre-Market

Harmony Biosciences Holdings, Inc. (HRMY) Live Price Chart

Last updated: ⁦2026-10-21 08:58:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Harmony Biosciences Holdings, Inc. (HRMY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $38.85, with a market capitalization of $2.19B and a P/E ratio of 12.43. Over the past 52 weeks, its price has ranged from $25.81 to $43.49. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.19B
Open	$38.75
Day's High	$62.09
Day's Low	$18.61
Previous Close	$38.70
Volume	1.00
Average Volume	878.09K
P/E Ratio	12.43
52-Week High	$43.49
52-Week Low	$25.81
Dividend Yield	--
Earnings Date	--

Harmony Biosciences Holdings, Inc. (HRMY) Pre-Market Stock Price

Harmony Biosciences Holdings, Inc. (HRMY) is trading at $38.85 in pre-market trading as of 2026-10-21 08:56:00, up 0.39% ($0.15) from the previous close of $38.70

Pre-market trading shows how investors are pricing HRMY before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Harmony Biosciences Holdings, Inc. (HRMY) 7-Day Stock Price Change

Over the past seven days, Harmony Biosciences Holdings, Inc. (HRMY) moved from $38.23 to $38.85, representing a gain of 1.62% ($0.62).

The stock traded between $35.99 and $39.89 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 1.01 million shares, up versus the previous seven-day period, indicating higher trading activity.

HRMY 52-Week Price Position

Position in Range: 73.8%

52W Low$25.81

52W High$43.49

HRMY is currently trading at $38.85, placing it 73.8% of the way from its 52-week low of $25.81 to its 52-week high of $43.49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Harmony Biosciences Holdings, Inc. (HRMY)?

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Harmony Biosciences Holdings, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	293
Exchange	NASDAQ
Company Website	https://www.harmonybiosciences.com

How to Buy Harmony Biosciences Holdings, Inc. (HRMY) Stock on MEXC

Eligible investors can buy real shares of Harmony Biosciences Holdings, Inc. (HRMY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for HRMY and Place Your Order

Open the RealStocks trading page and search for HRMY. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Harmony Biosciences Holdings, Inc. (HRMY) stock price today?

Harmony Biosciences Holdings, Inc. (HRMY) is currently trading at $ 38.85, up 0.39% ($0.15) from the previous close of $ 38.70. Intraday prices update in real time during regular trading hours.

2.Is HRMY stock going up or down today?

As of 2026-10-21 08:56:00, HRMY is trading at $ 38.85, up 0.39% ($0.15) from its previous close of $ 38.70. The stock has traded between $ 18.61 and $ 62.09 during today’s regular session. Past price movements do not guarantee future results.

3.What is HRMY pre-market price?

As of 2026-10-21 08:56:00, HRMY is trading at $ 38.85 in pre-market trading, up 0.39% ($0.15) from the previous close of $ 38.70. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is HRMY after-hours price?

As of 2026-10-21 08:56:00, HRMY is trading at $ 38.71 in after-hours trading, up 0.01% ($0.00) from the regular-session close of $ 38.70. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is HRMY stock trading now?

HRMY trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does HRMY sit relative to its 52-week high and low?

Over the past 52 weeks, HRMY has traded between a low of $ 25.81 and a high of $ 43.49. At $ 38.85, the stock is positioned 73.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Harmony Biosciences Holdings, Inc. in?

Harmony Biosciences Holdings, Inc. (HRMY) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Harmony Biosciences Holdings, Inc.'s market capitalization and where is it listed?

Harmony Biosciences Holdings, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 2.19B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is HRMY valued in terms of P/E ratio and EPS?

HRMY trades at a P/E ratio of 12.43, based on trailing-twelve-month EPS of $ 3.11. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Harmony Biosciences Holdings, Inc. pay a dividend?

Harmony Biosciences Holdings, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.